sr141716 has been researched along with bm 212 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, A; B, S; Gokhale, R; Kumar, V; Ramesh, R; Shingare, RD; Srinivasa Reddy, D; Ummanni, R; Veeraraghavan, S; Viswanadha, S | 1 |
1 other study(ies) available for sr141716 and bm 212
| Article | Year |
|---|---|
Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents.
Topics: Antitubercular Agents; Drug Repositioning; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Piperidines; Pyrazoles; Rimonabant; Structure-Activity Relationship | 2016 |